Related Experiment Videos
Microsatellite instability in Muir-Torre syndrome
R Honchel1, K C Halling, D J Schaid
1Department of Laboratory Medicine and Pathology, Mayo Clinic Foundation, Rochester, Minnesota 55905.
Cancer Research
|March 1, 1994
Summary
Muir-Torre syndrome (MTS) patients with microsatellite instability (MIN) exhibit earlier colorectal cancer onset and longer survival. This suggests a shared genetic link between MTS and hereditary nonpolyposis colorectal carcinoma (HNPCC).
Area of Science:
- Oncology
- Genetics
- Cancer Research
Background:
- Muir-Torre syndrome (MTS) is a rare disorder characterized by sebaceous tumors and visceral malignancies, frequently colorectal cancer.
- Hereditary nonpolyposis colorectal carcinoma (HNPCC) shares clinical and pathological similarities with MTS, suggesting common genetic underpinnings.
- Microsatellite instability (MIN) is a known feature in HNPCC, indicating potential DNA repair pathway defects.
Purpose of the Study:
- To investigate the presence and significance of microsatellite instability (MIN) in tumors from Muir-Torre syndrome (MTS) patients.
- To explore the potential shared genetic mechanisms between MTS and HNPCC through MIN analysis.
- To identify distinct clinical and pathological subgroups within MTS based on MIN status.
Main Methods:
- DNA analysis of microsatellite instability (MIN) at specific chromosomal loci ((CA)n repeats on 5q, 15q, 17p, 18q).
- Examination of paraffin-embedded tumor tissues from 13 MTS patients, including sebaceous, colorectal, and other visceral tumors.
- Comparison of clinical features (age of onset, survival, tumor burden) between MTS patients with and without MIN.
Main Results:
- Six out of 13 MTS patients demonstrated widespread MIN in their tumors, including sebaceous, colorectal, renal pelvis, and prostate cancers.
- MTS patients with MIN exhibited significantly earlier onset of colorectal cancer (average age 40 vs. 70) compared to those without MIN.
- Patients with MIN showed prolonged survival after visceral malignancy diagnosis (median 32 vs. 11 years) and a higher number of visceral and skin tumors.
Conclusions:
- MTS may comprise at least two distinct subgroups with differing genetic, pathological, and clinical characteristics.
- The subgroup of MTS patients with MIN likely shares similar genetic tumorigenesis mechanisms with HNPCC, supporting an allelic relationship.
- MIN serves as a potential biomarker for identifying a subset of MTS patients with distinct disease progression and prognosis.